EP 0684841 A1 19951206 - PROTEIN CONJUGATES, COMPOSITIONS CONTAINING THEM AND THEIR APPLICATIONS AS MEDICAMENT.
Title (en)
PROTEIN CONJUGATES, COMPOSITIONS CONTAINING THEM AND THEIR APPLICATIONS AS MEDICAMENT.
Title (de)
PROTEIN-KONJUGATE, DIESE ENTHALTENDE ZUSAMMENSETZUNGEN UND IHRE VERWENDUNG ALS ARZNEIMITTEL.
Title (fr)
CONJUGUES PROTEIQUES, COMPOSITIONS LES CONTENANT ET LEURS APPLICATIONS EN TANT QUE MEDICAMENT.
Publication
Application
Priority
- FR 9301833 A 19930218
- FR 9400183 W 19940218
Abstract (en)
[origin: WO9419021A1] Protein conjugates with specific affinity to appropriate target cells, and more particularly to cancer cells, as well as their applications as anti-cancer medicament (cytolytic properties). Said protein conjugates, of the type comprising a non specific portion and a portion having a particular affinity for a specific type of target cells, are characterized in that the portion having such particular affinity for a specific type of target cells is alpha -foetoprotein, and the non specific portion of said conjugate is selected in the group including the cytotoxic substances selected from animal toxins, plant toxins, cytolytic enzymes and low molecular weight active anti-cancer principles.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 31/19 (2006.01); A61K 31/475 (2006.01); A61K 31/505 (2006.01); A61K 31/70 (2006.01); A61K 33/24 (2006.01); A61K 47/48 (2006.01); C07K 14/47 (2006.01); C07K 19/00 (2006.01)
CPC (source: EP)
A61K 47/62 (2017.07)
Citation (search report)
See references of WO 9419021A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9419021 A1 19940901; CA 2155953 A1 19940901; EP 0684841 A1 19951206; FR 2701710 A1 19940826; FR 2701710 B1 19950421; JP H08509698 A 19961015
DOCDB simple family (application)
FR 9400183 W 19940218; CA 2155953 A 19940218; EP 94907594 A 19940218; FR 9301833 A 19930218; JP 51871094 A 19940218